Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

Biosensor Technology Could Allow Rapid Ebola Detection

October 28, 2014 2:18 pm | News | Comments

In 2010, a study reported the rapid detection of Ebola virus using new biosensor technology. There was little interest in developing the technology at the time, but now, in the wake of an Ebola outbreak, the researcher plans to resume his work on virus detection.

TOPICS:

Vitamin D Deficiency Ups Attack Risk in Asthmatics

October 28, 2014 2:03 pm | News | Comments

A new study points to a convenient, free way to manage acute asthmatic episodes— catching some rays outside. The research showed that asthmatics with vitamin D deficiency were 25 percent more likely to experience acute attacks.       

TOPICS:

Algae Virus Found in Healthy Human Throats

October 28, 2014 1:51 pm | News | Comments

Scientists have discovered an algae virus never before seen in the throats of healthy people that may subtly alter a range of cognitive functions including visual processing and spatial orientation in those who harbor it.         

TOPICS:
Advertisement

Nurse Free of Ebola, Released from Hospital

October 28, 2014 1:26 pm | by Ray Henry - Associated Press - Associated Press | News | Comments

Amber Vinson, a nurse who fueled Ebola fears by flying to Cleveland after being infected by her dying patient in Dallas, is now virus-free, and was celebrated Tuesday by her caregivers as courageous and passionate before getting out of the hospital.

TOPICS:

Patient-relevant Preclinical Models Using Image-guided Small Animal Irradiation

October 28, 2014 11:33 am | by Dr. Rajendra Kumari, Chief Scientific Officer, PRECOS Ltd., a Crown Bioscience Company | Articles | Comments

Radiotherapy is a primary, adjuvant or neoadjuvant treatment for a number of different cancers, such as glioblastoma, breast, lung and prostate. Image-guided radiation therapy (IGRT) is used to reduce the amount of radiation delivered to the normal tissue surrounding the targeted tumor. However, in the preclinical setting, the use of IGRT is less common.

TOPICS:

Federal health official Fauci: States have options

October 28, 2014 8:26 am | by Josh Lederman - Associated Press - Associated Press | News | Comments

For Americans wondering why President Barack Obama hasn't forced all states to follow a single, national rule for isolating potential Ebola patients, the White House has a quick retort: Talk to the Founding Fathers. A hodgepodge of state policies, some of which directly contradict Obama's...

Ebola nurse who was quarantined now in Maine

October 28, 2014 8:26 am | by Robert F. Bukaty - Associated Press - Associated Press | News | Comments

A nurse who treated Ebola patients in West Africa agreed to be quarantined in Maine upon her return from a weekend of confinement in New Jersey, but her lawyer disagrees with officials over how long she'll have to stay in seclusion. Nurse Kaci Hickox left a New Jersey hospital on Monday and...

Swiss drug maker Novartis posts strong profit

October 28, 2014 8:26 am | by The Associated Press | News | Comments

Swiss pharmaceutical giant Novartis AG has posted a 45 percent rise in net profit in the third quarter, boosted by strong sales of new products such as Gilenya for multiple sclerosis and the leukemia drug Tasigna. The Basel, Switzerland-based company's reported quarterly net profit was $3.24...

Advertisement

Pfizer's 3Q beats on emerging market growth

October 28, 2014 8:26 am | by Matthew Perrone - AP Health Writer - Associated Press | News | Comments

Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection. The New York drugmaker reported third-quarter profit of $2.67 billion, or 42 cents per...

5,000 Ebola health care workers needed in W Africa

October 28, 2014 7:26 am | by Elias Meseret - Associated Press - Associated Press | News | Comments

ADDIS ABABA, Ethiopia (AP) — More than 5,000 additional health care workers are needed to fight Ebola in the three most affected countries in West Africa, the president of the World Bank said Tuesday. Jim Yong Kim said he is worried about where those health care workers can be found given the...

Swiss agency approves trial for Ebola vaccine

October 28, 2014 6:25 am | by The Associated Press | News | Comments

The Swiss agency that regulates new drugs has approved the application for a clinical trial with an experimental Ebola vaccine at the Lausanne University Hospital. Swissmedic says the trial will be conducted on 120 volunteer participants with support from the U.N. World Health Organization. The...

CDC: New restrictions for those at high Ebola risk

October 27, 2014 6:27 pm | by Mike Stobbe - AP Medical Writer - Associated Press | News | Comments

U.S. health officials are recommending that people who are at highest risk for coming down with Ebola avoid commercial travel or attending large public gatherings, even if they have no symptoms. The Centers for Disease Control and Prevention issued the updated advice to state and local officials...

CDC: Voluntary quarantine fine for high Ebola risk

October 27, 2014 5:25 pm | by Mike Stobbe - AP Medical Writer - Associated Press | News | Comments

U.S. health officials on Monday recommended little more than voluntary, at-home quarantine for travelers from West Africa who are at highest risk for coming down with Ebola, and symptom monitoring for those at lower risk. The Centers for Disease Control and Prevention issued the updated guidance...

Ebola quarantine policies spread, despite science

October 27, 2014 3:26 pm | by David Porter - Associated Press - Associated Press | News | Comments

Despite President Barack Obama's appointment of an "Ebola czar" to oversee and coordinate the U.S. response to the deadly outbreak, some politicians and even an Army general are going against White House guidance, submitting people to the kinds of quarantines that scientists warn could make...

Endonuclease for Purification of Biological Molecules

October 27, 2014 3:26 pm | Product Releases | Comments

DENARASE endonuclease from Sartorius Stedim Biotech is a genetically engineered endonuclease from Serratia marcescens and used in purification processes of biological molecules.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading